Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Dine Brands
DIN
$450M
| $337K | ﹤0.01% |
5,170
-10,980
| -68% | -$784K |
|
3002
LendingTree
TREE
$447M
| $337K | ﹤0.01% |
7,678
-2,762
| -26% | -$205K |
|
3003
Scholastic
SCHL
$753M
| $336K | ﹤0.01% |
9,346
-26,212
| -74% | -$968K |
|
3004
Mesa Laboratories
MLAB
$565M
| $335K | ﹤0.01% |
1,642
-2,542
| -61% | -$557K |
|
|
SRNE
3005
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $335K | ﹤0.01% |
166,620
+115,761
| +228% | +$200K |
|
3006
Oil States International
OIS
$501M
| $334K | ﹤0.01% |
61,601
-56,114
| -48% | -$392K |
|
|
TBCH
3007
Turtle Beach Corp
TBCH
$249M
| $334K | ﹤0.01% |
27,273
+12,142
| +80% | +$207K |
|
|
PCSB
3008
DELISTED
PCSB Financial Corporation
PCSB
| $334K | ﹤0.01% |
17,506
-1,406
| -7% | -$26.5K |
|
3009
Atea Pharmaceuticals
AVIR
$399M
| $333K | ﹤0.01% |
46,940
-15,070
| -24% | -$103K |
|
3010
International Money Express
IMXI
$367M
| $333K | ﹤0.01% |
16,270
-2,551
| -14% | -$51.1K |
|
3011
Cannae Holdings
CNNE
$652M
| $332K | ﹤0.01% |
17,159
-15,602
| -48% | -$327K |
|
3012
Gogo Inc
GOGO
$492M
| $332K | ﹤0.01% |
20,455
+10,529
| +106% | +$200K |
|
|
BQ
3013
Boqii Holding Ltd
BQ
$5.95M
| $331K | ﹤0.01% |
5,141
| – | – |
|
|
ADAM
3014
Adamas Trust
ADAM
$856M
| $331K | ﹤0.01% |
29,918
-46,757
| -61% | -$573K |
|
|
ASPC
3015
DELISTED
Alpha Capital Acquisition Co
ASPC
| $331K | ﹤0.01% |
33,422
| – | – |
|
|
NPTN
3016
DELISTED
NEOPHOTONICS CORP
NPTN
| $331K | ﹤0.01% |
21,042
-1,017
| -5% | -$15.5K |
|
3017
Sprott Physical Gold and Silver Trust
CEF
$7.83B
| $329K | ﹤0.01% |
19,561
| – | – |
|
3018
1st Source
SRCE
$2.15B
| $329K | ﹤0.01% |
7,255
-9,212
| -56% | -$415K |
|
|
MODV
3019
DELISTED
ModivCare
MODV
| $328K | ﹤0.01% |
3,870
-6,145
| -61% | -$621K |
|
|
TWNI
3020
DELISTED
Tailwind International Acquisition Corp.
TWNI
| $328K | ﹤0.01% |
33,403
| – | – |
|
|
GIIX
3021
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
| $328K | ﹤0.01% |
33,315
-41,685
| -56% | -$412K |
|
3022
Beazer Homes USA
BZH
$915M
| $327K | ﹤0.01% |
27,087
-11,044
| -29% | -$161K |
|
3023
Methanex
MEOH
$4.21B
| $327K | ﹤0.01% |
8,542
+5,474
| +178% | +$270K |
|
3024
Bristow Group
VTOL
$1.33B
| $327K | ﹤0.01% |
13,974
-9,155
| -40% | -$270K |
|
|
HAACU
3025
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
| $327K | ﹤0.01% |
33,064
| – | – |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.